Detalhe da pesquisa
1.
Tyvaso DPI: Drug-device characteristics and patient clinical considerations.
Pulm Pharmacol Ther
; 83: 102266, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37967762
2.
Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension.
Adv Ther
; 41(2): 618-637, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38055186
3.
Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes.
Chest
; 163(2): 398-406, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36115497
4.
Parenteral treprostinil induction for rapid attainment of therapeutic doses of oral treprostinil.
Respir Med
; 218: 107374, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37532157
5.
Implementing the EXPEDITE parenteral induction protocol: Rapid parenteral treprostinil titration and transition to oral treprostinil.
Pulm Circ
; 13(3): e12255, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37497167
6.
The heart of the matter: Right heart imaging indicators for treatment escalation in pulmonary arterial hypertension.
Pulm Circ
; 13(2): e12240, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37222992
7.
Real-world dosing characteristics and utilization of parenteral treprostinil in the outpatient setting.
Pulm Circ
; 12(1): e12016, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-35506102
8.
Clinical application of risk assessment in PAH: Expert center APRN recommendations.
Pulm Circ
; 12(3): e12106, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36016667
9.
Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension.
Respir Med
; 193: 106744, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35134631
10.
Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EV.
J Heart Lung Transplant
; 41(11): 1572-1580, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36117055
11.
An expert panel Delphi consensus statement on the use of palliative care in the management of patients with pulmonary arterial hypertension.
Pulm Circ
; 12(1): e12003, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-35506067
12.
The effect of sleep disturbance on quality of life in women with ovarian cancer.
Gynecol Oncol
; 123(2): 351-5, 2011 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-21855973
13.
Combination Therapy in Pulmonary Arterial Hypertension-Targeting the Nitric Oxide and Prostacyclin Pathways.
J Cardiovasc Pharmacol Ther
; 26(5): 453-462, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33836637
14.
Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times daily.
Pulm Circ
; 11(4): 20458940211052228, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34733493
15.
A multicenter retrospective study of patients with pulmonary hypertension transitioned from inhaled to oral treprostinil.
Pulm Circ
; 11(1): 2045894021998203, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33738096
16.
Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease.
Mov Disord
; 25(14): 2296-303, 2010 Oct 30.
Artigo
Inglês
| MEDLINE | ID: mdl-20976736
17.
Novel dose-response analyses of treprostinil in pulmonary arterial hypertension and its effects on six-minute walk distance and hospitalizations.
Pulm Circ
; 10(3): 2045894020923956, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-35154662
18.
Impact of inhaled treprostinil on risk stratification with noninvasive parameters: a post hoc analysis of the TRIUMPH and BEAT studies.
Pulm Circ
; 10(4): 2045894020977025, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33403101
19.
Dosing characteristics of oral treprostinil in real-world clinical practice.
Pulm Circ
; 8(2): 2045894018770654, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29582710
20.
Transition from parenteral to oral treprostinil in pulmonary arterial hypertension.
J Heart Lung Transplant
; 36(2): 193-201, 2017 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-27469018